Psychiatry Tomorrow

Clinical Trials and Breakthrough Treatments with Michael Banov, MD

Jan 10, 2024

50:49

Explore the dynamic landscape of psychiatric clinical trials through the expert lens of Dr. Michael Banov, a renowned figure with a wealth of experience in over 150 trials. This in-depth blog post delves into his groundbreaking journey, starting with the revolutionary Clozapine trial for depression and extending to the recent developments in Vagus Nerve Stimulators (VNS). Gain an unparalleled understanding of the challenges and advancements in clinical trials, including the transition from traditional methods to innovative approaches. Dr. Banov shares his valuable insights on patient recruitment complexities, the importance of real-world scenarios in trials, and the critical role of ethical oversight. Discover the impact of technology on patient engagement and the intricacies of conducting trials in a modern, regulated environment. This comprehensive guide is an essential read for clinicians and professionals interested in the evolving world of psychiatric research and its profound implications for the future of mental health care.

Timestamps:

[00:00:00] Introduction to the podcast and mention of ketamine treatments and vagus nerve stimulators.
[00:01:00] Introduction of Dr. Michael Banov and his background in clinical trials.
[00:02:00] Discussion on the challenges of recruiting for psychiatric clinical trials.
[00:03:00] Insights into the evolution of clinical trial landscapes and the role of social media in recruitment.
[00:04:00] Introduction to the trial of vagal nerve stimulation for depression.
[00:05:00] Discussion on the potential of vagal nerve stimulator trials for treatment-resistant depression.
[00:06:00] Dr. Banov's career highlights and how to get involved in clinical trials.
[00:07:00] Dr. Banov's first clinical trial experience and the use of Clozapine.
[00:08:00] The transition from academic research to industry and the ethical considerations.
[00:09:00] Challenges faced in starting clinical research and the importance of experience.
[00:10:00] The shift in psychiatric treatment approaches and the role of industry professionals.
[00:11:00] Insights into the pharmaceutical industry and the development of medications.
[00:12:00] The process of recruiting for a Clozapine trial and the challenges involved.
[00:13:00] The key role of recruitment in clinical research and the evolution of patient protection.
[00:14:00] The increasing challenges in recruiting for clinical trials.
[00:15:00] The impact of clinical trials on real-world treatment scenarios.
[00:16:00] The unique aspects of running psilocybin clinical trials.
[00:17:00] Challenges in placebo control and patient interaction in psilocybin trials.
[00:18:00] The necessity of a placebo script in clinical trials.
[00:19:00] The regulatory aspects of clinical trials and the importance of consent forms.
[00:20:00] Reflections on the changing landscape of psychiatric clinical trials.
[00:21:00] The shift towards more regulated clinical trials and the loss of nuanced patient interaction.
[00:22:00] The impact of private equity on research organizations and clinical trials.
[00:23:00] The role of technology in modern clinical trials.
[00:24:00] The challenges introduced by technology in clinical trials.
[00:25:00] The use of technology for monitoring patient compliance in trials.
[00:26:00] The importance of oversight in clinical trials.
[00:27:00] The process of being monitored and audited in clinical trials.
[00:28:00] The role of Contract Research Organizations (CROs) in clinical trials.
[00:29:00] The process of site initiation and monitoring in clinical trials.
[00:30:00] The reasons for FDA audits in clinical trials.
[00:31:00] The consequences of FDA audits and the importance of ethical conduct.
[00:32:00] The challenges of being a high enroller in clinical trials.
[00:33:00] The role of technology in patient recruitment and enrollment.
[00:34:00] The challenges of recruiting patients in active clinical practice.
[00:35:00] The implementation and mechanism of vagal nerve stimulators.
[00:36:00] The contrast between VNS and other treatments like ketamine.
[00:37:00] The design of the VNS trial and its benefits.
[00:38:00] The steps to become a site researcher in clinical trials.
[00:39:00] The importance of experience and connections in starting clinical research.
[00:40:00] The necessity of oversight in clinical trials for patient safety.
[00:41:00] The role of technology in facilitating patient identification and enrollment.
[00:42:00] The challenges of using social media for recruitment in clinical trials.
[00:43:00] The practical aspects of running a VNS study in a clinical practice.
[00:44:00] The process and placement of the VNS unit.
[00:45:00] The sustained response of VNS compared to other treatments.
[00:46:00] The sponsor of the VNS study and the cost considerations.
[00:47:00] The trial design of VNS and its real-world applicability.
[00:48:00] Advice for clinicians interested in becoming involved in clinical trials.
[00:49:00] The importance of gaining experience and certifications in clinical research.